Company page

Krystal Biotech, Inc.

Krystal Biotech, Inc. (ticker: KRYS) is a public company based in the United States with a market capitalization of approximately $10.78 billion. The company focuses on developing innovative gene therapies for various dermatological conditions. Krystal Biotech aims to address unmet medical needs through its proprietary technology platform.